These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11127293)

  • 21. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the aromatase inhibitor letrozole on in utero development in rats.
    Tiboni GM; Marotta F; Rossi C; Giampietro F
    Hum Reprod; 2008 Aug; 23(8):1719-23. PubMed ID: 18487213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.
    Goss PE; Qi S; Cheung AM; Hu H; Mendes M; Pritzker KP
    Clin Cancer Res; 2004 Sep; 10(17):5717-23. PubMed ID: 15355898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aromatase inhibitors in metastatic breast cancer.
    Buzdar AU; Plourde PV; Hortobagyi GN
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):28-32. PubMed ID: 8824462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed implantation induced by fadrozole hydrochloride in rats.
    Tamada H; Mizuta Y; Kawate N; Inaba T; Sawada T
    Contraception; 2003 Jul; 68(1):65-8. PubMed ID: 12878290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of estrogen in the male rat medial amygdala: infusion of an aromatase inhibitor lowers mating and bovine serum albumin-conjugated estradiol implants do not promote mating.
    Huddleston GG; Paisley JC; Clancy AN
    Neuroendocrinology; 2006; 83(2):106-16. PubMed ID: 16825796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A letrozole-based dual aromatase-sulphatase inhibitor with in vivo activity.
    Wood PM; Woo LW; Humphreys A; Chander SK; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):123-30. PubMed ID: 15862957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New breast cancer drug.
    Brink S
    US News World Rep; 2001 Dec; 131(26):52. PubMed ID: 11793594
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
    Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
    Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hippocampal estrogen synthesis causes region-specific downregulation of synaptic protein expression in hippocampal neurons.
    Prange-Kiel J; Fester L; Zhou L; Lauke H; Carrétero J; Rune GM
    Hippocampus; 2006; 16(5):464-71. PubMed ID: 16502389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
    Belosay A; Brodie AM; Njar VC
    Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ; Jelovac D; Thiantanawat A; Brodie AM
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen synthesis inhibitors: from "off the rack" to haute couture.
    Santen RJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):316-8. PubMed ID: 8345033
    [No Abstract]   [Full Text] [Related]  

  • 34. Immoderate inhibition of estrogen by anastrozole enhances the severity of experimental polyarthritis.
    Wang J; Zhang Q; Jin S; Feng M; Kang X; Zhao S; Liu S; Zhao W
    Exp Gerontol; 2009; 44(6-7):398-405. PubMed ID: 19298850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYSTS OF THE EPIDIDYMIS, CANCER OF THE CERVIX, GRANULAR CELL MYOBLASTOMA, AND OTHER LESIONS AFTER ESTROGEN INJECTION IN NEWBORN MICE.
    DUNN TB; GREEN AW
    J Natl Cancer Inst; 1963 Aug; 31():425-55. PubMed ID: 14046632
    [No Abstract]   [Full Text] [Related]  

  • 37. Granular cell tumor of the thyroid gland in a girl receiving high-dose estrogen therapy.
    Mahoney CP; Patterson SD; Ryan J
    Pediatr Pathol Lab Med; 1995; 15(5):791-5. PubMed ID: 8597864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granular Cell Tumors of the Gastrointestinal Tract: Questions and Answers.
    Radaelli F; Minoli G
    Gastroenterol Hepatol (N Y); 2009 Nov; 5(11):798-800. PubMed ID: 37967389
    [No Abstract]   [Full Text] [Related]  

  • 39. Granular cell tumor of the biliary tract.
    Patel AJ; Jakate SM
    Gastroenterol Hepatol (N Y); 2010 May; 6(5):331-6. PubMed ID: 20567590
    [No Abstract]   [Full Text] [Related]  

  • 40. Nonproliferative and proliferative lesions of the rat and mouse female reproductive system.
    Dixon D; Alison R; Bach U; Colman K; Foley GL; Harleman JH; Haworth R; Herbert R; Heuser A; Long G; Mirsky M; Regan K; Van Esch E; Westwood FR; Vidal J; Yoshida M
    J Toxicol Pathol; 2014; 27(3-4 Suppl):1S-107S. PubMed ID: 25516636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.